ArticleBreast cancer research : BCR2019

Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.

Doris Leithner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.